Literature DB >> 24154878

Comprehensive gene expression analysis reveals multiple signal pathways associated with prostate cancer.

Yi Liu1, Hua Song, Jing Pan, Jing Zhao.   

Abstract

Prostate cancer (PC) depends on androgenic signaling for growth and survival. To data, the exact molecular mechanism of hormone controlling proliferation and tumorigenesis in the PC remains unclear. Therefore, in this study, we explored the differentially expressed genes (DEGs) and identified featured genes related to hormone stimulus from PC. Two sets of gene expression data, including PC and normal control sample, were downloaded from Gene Expression Omnibus (GEO) database. The t-test was used to identify DEGs between PC and controls. Gene ontology (GO) functional annotation was applied to analyze the function of DEGs and screen hormone-related DEGs. Then these hormone-related DEGs were further analyzed in constructed cancer network and Human Protein Reference Database to screen important signaling pathways they participated in. A total of 912 DEGs were obtained which included 326 up-regulated genes and 586 down-regulated genes. GO functional enrichment analysis identified 50 hormone-related DEGs associated with PC. After pathway and PPI network analysis, we found these hormone-related DEGs participated in several important signaling pathways including TGF-β (TGFB2, TGFB3 and TGFBR2), MAPK (TGFB2, TGFB3 and TGFBR2), insulin (PIK3R3, SHC1 and EIF4EBP1), and p53 signaling pathways (CCND2 and CDKN1A). In addition, a total of five hormone-related DEGs (SHC1, CAV1, RXRA, CDKN1A and SRF) were located in the center of PPI network and 12 hormone-related DEGs formed six protein modules. These important signal pathways and hormone-related DEGs may provide potential therapeutic targets for PC.

Entities:  

Mesh:

Year:  2013        PMID: 24154878     DOI: 10.1007/s13353-013-0174-9

Source DB:  PubMed          Journal:  J Appl Genet        ISSN: 1234-1983            Impact factor:   3.240


  45 in total

Review 1.  Growth factor regulation of the novel class II phosphoinositide 3-kinases.

Authors:  R A Brown; P R Shepherd
Journal:  Biochem Soc Trans       Date:  2001-08       Impact factor: 5.407

2.  NKX3.1 as a marker of prostatic origin in metastatic tumors.

Authors:  Bora Gurel; Tehmina Z Ali; Elizabeth A Montgomery; Shahnaz Begum; Jessica Hicks; Michael Goggins; Charles G Eberhart; Douglas P Clark; Charles J Bieberich; Jonathan I Epstein; Angelo M De Marzo
Journal:  Am J Surg Pathol       Date:  2010-08       Impact factor: 6.394

3.  Uncovering the overlapping community structure of complex networks in nature and society.

Authors:  Gergely Palla; Imre Derényi; Illés Farkas; Tamás Vicsek
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

Review 4.  The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism.

Authors:  Jeffrey A Engelman; Ji Luo; Lewis C Cantley
Journal:  Nat Rev Genet       Date:  2006-08       Impact factor: 53.242

5.  The relative impact and future burden of prostate cancer in the United States.

Authors:  June M Chan; Ronald M Jou; Peter R Carroll
Journal:  J Urol       Date:  2004-11       Impact factor: 7.450

6.  Isolation and androgen regulation of the human homeobox cDNA, NKX3.1.

Authors:  J L Prescott; L Blok; D J Tindall
Journal:  Prostate       Date:  1998-04-01       Impact factor: 4.104

7.  Identifying biological themes within lists of genes with EASE.

Authors:  Douglas A Hosack; Glynn Dennis; Brad T Sherman; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-09-11       Impact factor: 13.583

8.  Human Protein Reference Database and Human Proteinpedia as discovery tools for systems biology.

Authors:  T S Keshava Prasad; Kumaran Kandasamy; Akhilesh Pandey
Journal:  Methods Mol Biol       Date:  2009

9.  Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer.

Authors:  Rohit Mehra; Scott A Tomlins; Jianjun Yu; Xuhong Cao; Lei Wang; Anjana Menon; Mark A Rubin; Kenneth J Pienta; Rajal B Shah; Arul M Chinnaiyan
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

Review 10.  Role of transforming growth factor-beta superfamily signaling pathways in human disease.

Authors:  Kelly J Gordon; Gerard C Blobe
Journal:  Biochim Biophys Acta       Date:  2008-02-11
View more
  5 in total

1.  A human fetal prostate xenograft model of developmental estrogenization.

Authors:  Camelia M Saffarini; Elizabeth V McDonnell-Clark; Ali Amin; Kim Boekelheide
Journal:  Int J Toxicol       Date:  2015-01-29       Impact factor: 2.032

2.  Identification and comparison of aberrant key regulatory networks in breast, colon, liver, lung, and stomach cancers through methylome database analysis.

Authors:  Byungtak Kim; Seongeun Kang; Gookjoo Jeong; Sung-Bin Park; Sun Jung Kim
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

3.  Developmental exposure to estrogen alters differentiation and epigenetic programming in a human fetal prostate xenograft model.

Authors:  Camelia M Saffarini; Elizabeth V McDonnell-Clark; Ali Amin; Susan M Huse; Kim Boekelheide
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

4.  Cyr61: a potential therapeutic target for prostate cancer.

Authors:  Chang-Ming Lin; Chao-Zhao Liang
Journal:  Asian J Androl       Date:  2014 Sep-Oct       Impact factor: 3.285

5.  miRNA-186 inhibits prostate cancer cell proliferation and tumor growth by targeting YY1 and CDK6.

Authors:  Shu Lu; Ming-Shan Wang; Pei-Jie Chen; Qiang Ren; Peiming Bai
Journal:  Exp Ther Med       Date:  2017-04-26       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.